Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hyoun-Ah Kim"'
Autor:
Hyun Jeong Kim, Joohee Kim, Ju-Yang Jung, In Ah Choi, Kyung Eun Lee, Su Jin Oh, Hyoun-Ah Kim, Tae Hyeok Kim, Woorim Kim
Studies that investigate the association between toll-like receptor (TLR)-4 or TLR9 gene polymorphisms and remission from the disease in RA patients taking tumor necrosis factor alpha (TNF-α) inhibitors have yet to be conducted. In this context, thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c4adb8a9c34a5772e5edb3e9b7c5362
https://doi.org/10.21203/rs.3.rs-534605/v1
https://doi.org/10.21203/rs.3.rs-534605/v1
Autor:
Hong Ki Min, Hae-Rim Kim, Sang-Heon Lee, Kichul Shin, Hyoun-Ah Kim, Sung-Hwan Park, Seung-Ki Kwok
Background: To evaluate the impact of biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) on lipid profile and atherogenic index of plasma (AIP) in rheumatoid arthritis (RA) patients, and to compare the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29bc632489ebf39e690d5ee13e4df6db
https://doi.org/10.21203/rs.3.rs-32790/v1
https://doi.org/10.21203/rs.3.rs-32790/v1
Autor:
Wook-Young Baek, Sung-Min Lee, Chang-Hee Suh, Joo-Ho Shin, Jin-Young Nam, Hyoun-Ah Kim, Ju-Yang Jung, Keun-Sil Ryu
Background Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies and systemic inflammatory response. We aimed to characterize the salivary protein components and find biomarkers in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab68609ac552e637f83a4a4e0e42997
https://doi.org/10.21203/rs.3.rs-23170/v1
https://doi.org/10.21203/rs.3.rs-23170/v1
Autor:
Ju-Yang Jung, Woorim Kim, Kyung Hyun Min, Hyun Jeong Kim, Sang Oh Kang, Ha Rim Yeon, Kyung Eun Lee, Nga Thi Trinh, Joohee Kim, Hyoun-Ah Kim, In Ah Choi
Background: Despite the improvement from the introduction of tumor necrosis factor inhibitors (TNFi) in the rheumatoid arthritis (RA), TNFi therapy fails for more than 30% or results in a partial response. Thus, we aimed to explore treatment marker b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a73d898074a91b6c4f9d77cff6243ed9
https://doi.org/10.21203/rs.2.24442/v1
https://doi.org/10.21203/rs.2.24442/v1